The Tuberous Sclerosis Complex, caused by mutations in the TSC1 or TCS2 genes, results in abnormalities in cell growth and differentiation through disruption of the mTOR (mammalian target of rapamycin) pathway. This evidence concerns the gene MTOR and tuberous sclerosis.